136 related articles for article (PubMed ID: 25305067)
1. Assessing quality of life on the day of chemotherapy administration underestimates patients' true symptom burden.
Giesinger JM; Wintner LM; Zabernigg A; Gamper EM; Oberguggenberger AS; Sztankay MJ; Kemmler G; Holzner B
BMC Cancer; 2014 Oct; 14():758. PubMed ID: 25305067
[TBL] [Abstract][Full Text] [Related]
2. Quality of life across chemotherapy lines in patients with cancers of the pancreas and biliary tract.
Zabernigg A; Giesinger JM; Pall G; Gamper EM; Gattringer K; Wintner LM; Sztankay MJ; Holzner B
BMC Cancer; 2012 Sep; 12():390. PubMed ID: 22950826
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
4. The effects of an integrated supportive care intervention on quality of life outcomes in outpatients with breast and gynecologic cancer undergoing chemotherapy: Results from a randomized controlled trial.
Klafke N; Mahler C; von Hagens C; Uhlmann L; Bentner M; Schneeweiss A; Mueller A; Szecsenyi J; Joos S
Cancer Med; 2019 Jul; 8(8):3666-3676. PubMed ID: 31115192
[TBL] [Abstract][Full Text] [Related]
5. Monitoring physical and psychosocial symptom trajectories in ovarian cancer patients receiving chemotherapy.
Meraner V; Gamper EM; Grahmann A; Giesinger JM; Wiesbauer P; Sztankay M; Zeimet AG; Sperner-Unterweger B; Holzner B
BMC Cancer; 2012 Feb; 12():77. PubMed ID: 22373218
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
Leinert E; Singer S; Janni W; Harbeck N; Weissenbacher T; Rack B; Augustin D; Wischnik A; Kiechle M; Ettl J; Fink V; Schwentner L; Eichler M
Clin Breast Cancer; 2017 Apr; 17(2):100-106. PubMed ID: 27884722
[TBL] [Abstract][Full Text] [Related]
7. Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer.
Brown J; Thorpe H; Napp V; Fairlamb DJ; Gower NH; Milroy R; Parmar MK; Rudd RM; Spiro SG; Stephens RJ; Waller D; West P; Peake MD
J Clin Oncol; 2005 Oct; 23(30):7417-27. PubMed ID: 16157935
[TBL] [Abstract][Full Text] [Related]
8. Quality of life across chemotherapy lines in patients with advanced colorectal cancer: a prospective single-center observational study.
Mayrbäurl B; Giesinger JM; Burgstaller S; Piringer G; Holzner B; Thaler J
Support Care Cancer; 2016 Feb; 24(2):667-674. PubMed ID: 26123602
[TBL] [Abstract][Full Text] [Related]
9. The relationship between global and specific components of quality of life, assessed with the EORTC QLQ-C30 in a sample of 2019 cancer patients.
Hinz A; Mehnert A; Dégi C; Reissmann DR; Schotte D; Schulte T
Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26568527
[TBL] [Abstract][Full Text] [Related]
10. Patient Experiences With Oral Chemotherapy: Adherence, Symptoms, and Quality of Life.
Jacobs JM; Ream ME; Pensak N; Nisotel LE; Fishbein JN; MacDonald JJ; Buzaglo J; Lennes IT; Safren SA; Pirl WF; Temel JS; Greer JA
J Natl Compr Canc Netw; 2019 Mar; 17(3):221-228. PubMed ID: 30865917
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial.
Paccagnella A; Favaretto A; Oniga F; Barbieri F; Ceresoli G; Torri W; Villa E; Verusio C; Cetto GL; Santo A; De Pangher V; Artioli F; Cacciani GC; Parodi G; Soresi F; Ghi MG; Morabito A; Biason R; Giusto M; Mosconi P; Chiarion Sileni V;
Lung Cancer; 2004 Jan; 43(1):83-91. PubMed ID: 14698542
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial.
Brahmer JR; Rodríguez-Abreu D; Robinson AG; Hui R; Csőszi T; Fülöp A; Gottfried M; Peled N; Tafreshi A; Cuffe S; O'Brien M; Rao S; Hotta K; Zhang J; Lubiniecki GM; Deitz AC; Rangwala R; Reck M
Lancet Oncol; 2017 Dec; 18(12):1600-1609. PubMed ID: 29129441
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
[TBL] [Abstract][Full Text] [Related]
14. Quality of life during chemotherapy in lung cancer patients: results across different treatment lines.
Wintner LM; Giesinger JM; Zabernigg A; Sztankay M; Meraner V; Pall G; Hilbe W; Holzner B
Br J Cancer; 2013 Oct; 109(9):2301-8. PubMed ID: 24091620
[TBL] [Abstract][Full Text] [Related]
15. Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907.
Kornblith AB; Lan L; Archer L; Partridge A; Kimmick G; Hudis C; Winer E; Casey R; Bennett S; Cohen HJ; Muss HB
J Clin Oncol; 2011 Mar; 29(8):1022-8. PubMed ID: 21300923
[TBL] [Abstract][Full Text] [Related]
16. Quality of life of advanced ovarian cancer patients in the randomized phase III study comparing primary debulking surgery versus neo-adjuvant chemotherapy.
Greimel E; Kristensen GB; van der Burg ME; Coronado P; Rustin G; del Rio AS; Reed NS; Nordal RR; Coens C; Vergote I;
Gynecol Oncol; 2013 Nov; 131(2):437-44. PubMed ID: 23994107
[TBL] [Abstract][Full Text] [Related]
17. Quality of life trajectory in patients with advanced cancer during the last year of life.
Giesinger JM; Wintner LM; Oberguggenberger AS; Gamper EM; Fiegl M; Denz H; Kemmler G; Zabernigg A; Holzner B
J Palliat Med; 2011 Aug; 14(8):904-12. PubMed ID: 21711125
[TBL] [Abstract][Full Text] [Related]
18. High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment?
Macquart-Moulin G; Viens P; Palangié T; Bouscary ML; Delozier T; Roché H; Janvier M; Fabbro M; Moatti JP
J Clin Oncol; 2000 Feb; 18(4):754-64. PubMed ID: 10673516
[TBL] [Abstract][Full Text] [Related]
19. Integrating patient reported measures as predictive parameters into decisionmaking about palliative chemotherapy: a pilot study.
Creutzfeldt A; Suling A; Oechsle K; Mehnert A; Atanackovic D; Kripp M; Arnold D; Stein A; Quidde J
BMC Palliat Care; 2016 Mar; 15():25. PubMed ID: 26928745
[TBL] [Abstract][Full Text] [Related]
20. Quality-of-Life Analysis of the German Prospective Multicentre Trial of Single-cycle Adjuvant BEP Versus Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Tumours.
Flechtner HH; Fischer F; Albers P; Hartmann M; Siener R;
Eur Urol; 2016 Mar; 69(3):518-25. PubMed ID: 26620368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
